Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cellular immune system operates through a combination of direct cell-cell contact and the release of a complex secretome to coordinate host defense and maintain tissue homeostasis (NCBI, NBK279364). Cell-cell contact is mediated by specialized surface molecules, such as the interaction between the T-cell receptor (TCR) and the major histocompatibility complex (MHC), which is essential for antigen recognition and immune activation (PubMed, PMC3135642). Simultaneously, the secretome—comprising cytokines, chemokines, and extracellular vesicles—acts as a paracrine and endocrine signaling network to recruit and polarize immune cells (Nature Reviews Immunology, 2017). Dysregulation of these processes is central to the pathogenesis of various conditions, including cancer, where tumors evade immune detection, and autoimmune diseases, where the system attacks self-tissues (StatPearls, NBK459471). Therapeutic intervention often involves monoclonal antibodies that block inhibitory checkpoints or recombinant cytokines that stimulate immune effector functions (NIH, 2023). Because this term encompasses an entire physiological system and multiple signaling modalities, it does not represent a single druggable molecular target but rather a broad biological framework.
Modulation of immune cell communication through the agonism or antagonism of cell-surface receptors and the neutralization or supplementation of secreted signaling proteins (PubMed, PMC7151665).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular immune system via cell-cell contact and secretome.